Technology Offers Page 3

Consejo Superior de Investigaciones Científicas posted this:

Biocompatible self-generating cell stimulator CSIC through the Instituto de Microelectrónica de Barcelona - Centro Nacional de Microelectrónica,has developed a device based on nanogenerators for electrical cells stimulation without the need of electrodes or bulky devices. The device is biocompatible and, among its multiple applications, is able to actuate in medical prostheses as enhancer of cellular growth and proliferation, which permits an early lesion recovery (such as a fracture or wound). Industrial partners dedicated to the development of medical devices for cells stimulation, in particular, focused onto therapeutic treatments of non-healing wounds, are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing

Biocompatible self-generating cell stimulator CSIC through the Instituto de Microelectrónica de Barcelona - Centro Nacional de Microelectrónica,

Consejo Superior de Investigaciones Científicas posted this:

System to generate ultra-short high-power pulses in lasers CSIC have developed a method that allows to generate pulsed signals of high power and energy through control over the spatial distribution of the intensity, nonlinear effects and the dispersive characteristics inside a laser. This method offers interesting possibilities for the processing of laser materials, the generation of high bandwidth light sources, the development of sensors or optical metrology, as possible field of application. Industrial partners from in laser sector are being sought to collaborate through a patent licence agreement. An offer for Patent Licensing

System to generate ultra-short high-power pulses in lasers

Yissum - Research Development Company of the Hebrew University posted this:

Naturally Occurring Compounds for Treating Pathogenic Factors Common to Cystic Fibrosis Cannabis project Derivatives of cannabinoids have an antimicrobial and anti biofilm effect on pseudomonas and candida which are major ethological pathogenic factors in CF Project ID : 6-2019-6720

Yissum - Research Development Company of the Hebrew University posted this:

Platform for Neutrophil Specific Targeting as a Mode of Immunotherapy Dr. Zvika Granot, from the School of Medicine-IMRIC-Developmental Biology and Cancer Research, is working on a innovative approach for Neutrophil specific targeting of TGF-beta signaling as a novel anti-cancer therapy (see attached summary and several papers) Project ID : 6-2015-4241

Platform for Neutrophil Specific Targeting as a Mode of Immunotherapy

Yissum - Research Development Company of the Hebrew University posted this:

Development of 2,4-D Resistant Non-Transgenic Solanaceae Plants Researcher used transcriptomics to identify 5 crisper/cas KO targets for generating 2,4-D resistant tomatoes Project ID : 8-2016-4342

Yissum - Research Development Company of the Hebrew University posted this:

A Novel Biosensor for Detecting Wine Spoilage In the proposed research we describe a novel, efficient and low-cost approaches for detection of acetic acid in wines. The first technique is based on the interaction of acetic acid volatiles with a specific receptor from the bacterium Bacillus subtilis. The receptor, which is encoded within a bacterial biosensor, will activate a reporter gene in the presence of volatiles of acetic acid. Project ID : 8-2018-4662

A Novel Biosensor for Detecting Wine Spoilage

Yissum - Research Development Company of the Hebrew University posted this:

Personalized Phage Therapy: A New Paradigm for Combating Infectious Disease in the Age of Antibiotic Resistance A New Paradigm for Combating Infectious Disease in the Age of Antibiotic Resistance. Phage Therapy offers significant advantages: 1) Natural- Harnessing nature’s own enemy against bacteria 2) Smart kinetics Phages grow with bacteria and disappear in its absence 3) Can be manipulated (unlike antibiotics) Engineered / evolutionary developed 4) Efficient against biofilm Chain reaction of the phages 5) Do not harm the microbiome Highly specific to the target pathogen. Hazan's approach for a Personalized Phage Therapy suggests an adaptive and dynamic cocktail of phages and antibiotics , that are specially tailored using AI and machine learning prediction. Hazan et.al. offer a constantly increasing “Bank” of phages. Project ID : 43-2019-10746

Personalized Phage Therapy: A New Paradigm for Combating Infectious Disease in the Age of Antibiotic Resistance

Yissum - Research Development Company of the Hebrew University posted this:

Breeding Tef for Israeli Climate A novel method to breed Teff cultivars increasing Teff productivity in conditions different from Ethiopian drought and hot climate. A Breeding Program to Maximize the Quality of Teff Cultivars Project ID : 8-2014-3050

Breeding Tef for Israeli Climate

Yissum - Research Development Company of the Hebrew University posted this:

Novel Drug Delivery System of Large Molecules for Localized Sustained Release Novel Drug Delivery System of Large Molecules for Localized Sustained Release Project ID : 6-2018-4643

Yissum - Research Development Company of the Hebrew University posted this:

Novel Chimeric System for Targeted Killing of Lymphocytic Cancer Cells Novel Chimeric Protein utilizing components of the Ubiquitin-Proteasome System for targeted killing of Lymphocytic Cancer Cells Project ID : 6-2018-4687

Yissum - Research Development Company of the Hebrew University posted this:

New Methodology to Control Calcium Carbonate Morphology and Material State New Methodology to Control Calcium Carbonate Morphology and Material State Project ID : 6-2018-4599

Yissum - Research Development Company of the Hebrew University posted this:

New Target for the Treatment of Abdominal Obesity New target for the treatment of obesity and abdominal obesity by inhibiting the FGFR3 receptor signalling pathway Project ID : 7-2018-4658

Yissum - Research Development Company of the Hebrew University posted this:

Novel Method for Identifying Personalized Anti-Cancer Drug Combinations NanoCode - Identifying Best Fit Cancer Drug Combinations In-Vivo Project ID : 6-2019-6704

Yissum - Research Development Company of the Hebrew University posted this:

miRNA-Responsive Drug-Loaded NMOFs for the Targeted Treatment of Cancer miRNA-Responsive Drug-Loaded NMOFs for the Targeted Treatment of Cancer Project ID : 6-2019-6706

miRNA-Responsive Drug-Loaded NMOFs for the Targeted Treatment of Cancer

Yissum - Research Development Company of the Hebrew University posted this:

ORIS (‘280-4’) PASSION-FRUIT CULTIVAR – PURPLE WITH DARK PURPLE SPOTS AND 1.5-2X BIGGER A novel genotype of Passiflora edulis (Passion fruit) with an unusual and attractive peel color (pink/red/peach with purple spots), similar to Pomegranate/ star king apple, with fruit size ~2 + fold larger than the existent commercial varieties in Israel. 280-4, ORIS, A novel cultivar of Passionfruit (connected to 4676 project ) Project ID : 23-2019-6712

ORIS (‘280-4’) PASSION-FRUIT CULTIVAR – PURPLE WITH DARK PURPLE SPOTS AND 1.5-2X BIGGER

1
2
3
4
5